Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables strong binding to enzyme active sites, enhancing drug efficacy. Also employed in agrochemicals to improve metabolic stability and bioavailability of active ingredients. The trifluoromethyl group contributes to increased lipophilicity and resistance to oxidative degradation, making it valuable in designing long-acting compounds.